Fig. 1: BLM increased the number of CD41+ megakaryocytes in lung tissue of mice.
From: Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis

a The figure demonstrated a representative view of lung tissue on 14 days after the BLM injection (first panel: HE staining; second panel: DAPI; third panel: CD41 immunofluorescence; forth panel: CD31 immunofluorescence; fifth panel: Merge, × 400 magnification, CD41+ megakaryocytes marked by red arrow, Bar = 100 μm). b Data analysis of CD41+ megakaryocytes in lung tissue of mice (n = 3, **P < 0.01 vs control group). c The content of TPO protein in serum of mouse detected by ELISA (n = 3, **P < 0.01 vs control group). d The content of TPO protein in lung homogenate of mouse detected by ELISA (n = 3, **P < 0.01 vs control group). The data are presented as the mean ± SD